UNLEASHING THE NEXT GENERATION OF BIOTECHNOLOGY INNOVATION

Modern biotechnology is a young industry. But in just over four decades, the scientists, researchers and entrepreneurs working in this field have firmly established themselves at the forefront of medical innovation.

Spotlight

SMARTOX

Smartox Biotechnology is specialized in peptide research and engineering. The company is focused on the discovery and the synthesis of peptides coming from animal venoms. Venoms contain hundreds of bioactive peptide toxins including membrane receptor modulators (ion channels, GPCRs…) or anti-microbial peptides. Venom peptides have already demonstrated significative interest in various therapeutic areas such as pain, autoimmune disorders, cancers or cardiovascular disorders.

OTHER WHITEPAPERS
news image

Next-Generation Technology, Procedures, and Products Facilitate Biopreservation Best Practices for Cellular Therapies.

whitePaper | August 19, 2022

The quality of procedures and products used for preparing, transporting and storing cells at cryogenic temperatures have a direct impact on post-thaw viability and functionality, as well as the consistency and reliability of biological agents from a Quality perspective.

Read More
news image

Connecting materials sciences with fungal biology: a sea of possibilities

whitePaper | March 1, 2022

The Special Issue “Connecting materials science with fungal biology” celebrates recent breakthroughs in the fabrication of fungal-based materials, all of which have been made possible by the interdisciplinary and transdisciplinary collaboration of fungal biologists and biotechnologists with artists, designers, materials scientists, and architects

Read More
news image

BLOCKCHAIN ENABLED GENOME SECURITY FROM THE MOMENT IT IS SEQUENCED

whitePaper | June 8, 2022

Sequencing of human genomes is fast becoming an affordable technology for general consumer.

Read More
news image

Could DNA be the next big thing in data storage?

whitePaper | August 19, 2021

DNA storage technology is advancing rapidly. Atos is closely monitoring the development of this technology in the hope that future developments will make it a scalable, cost effective and crucially a decarbonized alternative to today’s carbon intensive technologies.

Read More
news image

Accurate and reliable cell counting using holographic microscopy and machine learning algorithms

whitePaper | August 11, 2022

Reliable and accurate cell counts are crucial for many different purposes such as the maintenance of cell cultures in biological research or in-process controls in industrial bioprocessing.

Read More
news image

Your Ultimate Guide to CMC Testing Support for Gene and Cell Therapy

whitePaper | December 6, 2022

The development of Advanced Therapy Medicinal Products such as gene and cell therapy products, has made significant progress in the treatment of many diseases, including cancer, genetic, and autoimmune disorders.

Read More

Spotlight

SMARTOX

Smartox Biotechnology is specialized in peptide research and engineering. The company is focused on the discovery and the synthesis of peptides coming from animal venoms. Venoms contain hundreds of bioactive peptide toxins including membrane receptor modulators (ion channels, GPCRs…) or anti-microbial peptides. Venom peptides have already demonstrated significative interest in various therapeutic areas such as pain, autoimmune disorders, cancers or cardiovascular disorders.

Events